RecruitingPhase 3NCT07674654
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
City of Saint Peters, MO · Hazelwood, MO · Kansas City, MO · +110 more sites
5 recruiting migraine studies with a site in Springfield, MO.
Sponsor: Kallyope Inc.
City of Saint Peters, MO · Hazelwood, MO · Kansas City, MO · +110 more sites
Sponsor: Pfizer
Ozark, MO · Springfield, MO · +167 more sites
Sponsor: Pfizer
Ozark, MO · Springfield, MO · +113 more sites
Sponsor: Kallyope Inc.
City of Saint Peters, MO · Hazelwood, MO · Kansas City, MO · +110 more sites
Sponsor: Pfizer
Springfield, MO · Weldon Spring, MO · +30 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.